Literature DB >> 4054433

Developmental and tissue-specific differential regulation of the mouse dioxin-inducible P1-450 and P3-450 genes.

N Tuteja, F J Gonzalez, D W Nebert.   

Abstract

The murine Ah locus has two structural genes, P1-450 and P3-450, that are members of the 2,3,7,8-tetrachlorodibenzo-p-dioxin-inducible P-450 gene family and are closely linked on mouse chromosomes 9. Transcriptional activation of both genes in liver is controlled by the Ah receptor. Inducible P1-450 mRNA is correlated with aryl hydrocarbon hydroxylase activity, whereas inducible P3-450 mRNA is correlated with acetanilide 4-hydroxylase activity. This report shows that inducible P3-450 mRNA is also highly correlated with estradiol 2-hydroxylase activity. Both P1-450 and P3-450 activities are induced by 3-methylcholanthrene in liver; in contrast, P1-450 but not P3-450 activity is induced to a significant extent in kidney, lung, and intestine. Constitutive levels of P3-450 mRNA in liver are at least five times greater than those of P1-450 mRNA, thus accounting for the much greater "fold inducibility" of aryl hydrocarbon hydroxylase than acetanilide 4-hydroxylase or estradiol 2-hydroxylase. The hepatic P3-450 induction response occurs at lower inducer concentrations than the P1-450 induction response, suggesting a difference in affinity of the inducer-receptor complex for regulatory regions of the two genes. Developmentally, P1-450 inducibility occurs at least 2 weeks earlier in gestation than P3-450 inducibility, which occurs near the time of birth. These data thus demonstrate striking differences between the expression of two homologous genes in the same P-450 subfamily, with respect to developmental and tissue specificity and sensitivity to common inducers that interact with the Ah receptor.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4054433     DOI: 10.1016/0012-1606(85)90131-9

Source DB:  PubMed          Journal:  Dev Biol        ISSN: 0012-1606            Impact factor:   3.582


  8 in total

1.  Cell-specific induction of mouse Cyp1a1 mRNA during development.

Authors:  A Dey; H Westphal; D W Nebert
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

2.  Marked increases in hepatic NAD(P)H:oxidoreductase gene transcription and mRNA levels correlated with a mouse chromosome 7 deletion.

Authors:  D D Petersen; F J Gonzalez; V Rapic; C A Kozak; J Y Lee; J E Jones; D W Nebert
Journal:  Proc Natl Acad Sci U S A       Date:  1989-09       Impact factor: 11.205

3.  The Ah domain of the mouse. Induction of proteins by the carcinogen 3-methylcholanthrene.

Authors:  G Silver; K S Krauter
Journal:  Biochem J       Date:  1988-05-15       Impact factor: 3.857

4.  Nuclear receptor coactivator SRC-1 interacts with the Q-rich subdomain of the AhR and modulates its transactivation potential.

Authors:  M B Kumar; G H Perdew
Journal:  Gene Expr       Date:  1999

5.  Cyp1a2(-/-) null mutant mice develop normally but show deficient drug metabolism.

Authors:  H C Liang; H Li; R A McKinnon; J J Duffy; S S Potter; A Puga; D W Nebert
Journal:  Proc Natl Acad Sci U S A       Date:  1996-02-20       Impact factor: 11.205

6.  Tissue-specific expression of the mouse dioxin-inducible P(1)450 and P(3)450 genes: differential transcriptional activation and mRNA stability in liver and extrahepatic tissues.

Authors:  S Kimura; F J Gonzalez; D W Nebert
Journal:  Mol Cell Biol       Date:  1986-05       Impact factor: 4.272

7.  Human cytochrome P-450 4 mRNA and gene: part of a multigene family that contains Alu sequences in its mRNA.

Authors:  L C Quattrochi; U R Pendurthi; S T Okino; C Potenza; R H Tukey
Journal:  Proc Natl Acad Sci U S A       Date:  1986-09       Impact factor: 11.205

8.  Inhibition of the aryl hydrocarbon receptor prevents Western diet-induced obesity. Model for AHR activation by kynurenine via oxidized-LDL, TLR2/4, TGFβ, and IDO1.

Authors:  Benjamin J Moyer; Itzel Y Rojas; Joanna S Kerley-Hamilton; Haley F Hazlett; Krishnamurthy V Nemani; Heidi W Trask; Rachel J West; Leslie E Lupien; Alan J Collins; Carol S Ringelberg; Barjor Gimi; William B Kinlaw; Craig R Tomlinson
Journal:  Toxicol Appl Pharmacol       Date:  2016-03-25       Impact factor: 4.219

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.